Data Factory
Reading the graph
Reading the graph
Venture Capital
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| NexCure Nov 2025 a Series of CGF2021 LLC | 2026 | Newly closed | $145,000 | $144,995 | 0 |
| Oncology Ventures Fund II LP | 2026 | Fundraising | $42.3M | $37.1M | 0 |
| Oncology Ventures Fund II-A LP | 2026 | Fundraising | $12.3M | $9.1M | 0 |
| RISA Nov 2024 a Series of CGF2021 LLC | 2025 | Newly closed | $491,000 | $481,180 | 0 |
| Tono Health Nov 2024 a Series of CGF2021 LLC | 2025 | Newly closed | $265,990 | $260,670 | 0 |
| Oncology Ventures Fund I-A LP | 2024 | Early deployment | $5.0M | $7.0M | 0 |
| Health Universe Dec 2023 a Series of CGF2021 LLC | 2024 | Early deployment | $246,000 | $246,000 | 0 |
| Concr Jun 2023 a Series of Cgf2021 LLC | 2023 | Active deployment | $410,990 | $410,990 | 0 |
| Vivor Care Jan 2023, a Series of Cgf2021 LLC | 2023 | Active deployment | $278,000 | $278,000 | 0 |
| Oncology Ventures Fund I LP | 2023 | Active deployment | $21.2M | $25.4M | 0 |
| Risa Series a Nov 2025 Series of Cgf2021 LLC | n/a | Unknown | n/a | $362,600 | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| RISA Labs | n/a | Series a | $11.1M | n/a | Unknown | Jan 13, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Oncology Ventures LLC | Cencora Ventures | 1 | 1 | Jan 13, 2026 | One time |
| Oncology Ventures LLC | Z21 Ventures | 1 | 1 | Jan 13, 2026 | One time |
| Oncology Ventures LLC | Optum Ventures | 1 | 1 | Jan 13, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): David Cohn (Interim Chief Executive Officer), Jenny Soriano (Manager), Ben Freeberg (Managing Partner), Khail Macadaeg (Executive Assistant), Emily Melton (Advisor), Nancy Brown (Advisor), Karen Knudsen (Advisor), Brad Hively (Advisor), Jennifer Malin (Advisor), Carolyn Starrett (Advisor), Jason Shook (Chief Operating Officer), Jay Freeberg (Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan